A Comparative Assessment of Rational Medicine Use in Primary Health Centres in Namrole and Leksula Districts Using WHO Indicators
DOI:
https://doi.org/10.831215/dhk0m140Keywords:
rational medicine use, WHO indicators, prescribing practices, patient care, primary health centresAbstract
Rational medicine use is essential to effective primary healthcare. This study compared medicine use in primary health centres in Namrole and Leksula using World Health Organization indicators. A comparative cross-sectional study was conducted at four centres between March and October 2024. Data collection comprised retrospective review of outpatient prescriptions issued between January and October 2024, interviews, direct observation and facility assessment. Prescriptions and 30 adult patients per centre were selected through systematic random sampling. Prescribing comparisons were assessed using the Mann–Whitney U test.
Mean medicine counts ranged from 3.85 to 4.09 per prescription. Generic prescribing ranged from 96.64% to 99.15%, antibiotic prescribing from 32.67% to 56.00%, and prescribing from the national essential medicines list from 85.67% to 90.47%. No injections were prescribed. Reported prescribing comparisons between centres with inpatient facilities were not statistically significant (p > 0.05). Although 97.56–100% of prescribed medicines were dispensed, adequate labelling ranged from 36.67% to 60.00%, and patient understanding from 43.33% to 66.67%. Leksula recorded higher labelling and understanding percentages within both facility categories.
High dispensing percentages contrasted with gaps in labelling and patient understanding. Improvement priorities include clearer medicine information, patient counselling and clinical review of prescribing; neither district demonstrated consistently better performance
References
Beecher, C. W. W. (1994). Cancer prevention properties of varieties of Brassica oleracea: A review. American Journal of Clinical Nutrition, 59(Suppl.), 1165S–1170S.
Bradfield, C. A., & Bjeldanes, L. F. (1991). Modification of carcinogen metabolism by indolylic autolysis products of Brassica oleracea. Advances in Experimental Medicine and Biology, 289, 153–163.
Cashman, J. R., Xiong, Y., Lin, J., Verhagen, H., van Poppel, G., van Bladeren, P. J., Larsen-Su, S., & Williams, D. S. (1999). In vitro and in vivo inhibition of human flavin-containing monooxygenase form 3 (FMO3) in the presence of dietary indoles. Biochemical Pharmacology, 58, 1047–1055.
Gibson, G. G., & Skett, P. (1986). Introduction to drug metabolism. London: Chapman and Hall.
Nugroho, A. E. (2000). Pengaruh praperlakuan brokoli (Brassica oleraceae L.) terhadap terhadap farmakokinetika tolbutamid pada tikus putih jantan [Laporan penelitian]. Yogyakarta: Lembaga Penelitian Universitas Gadjah Mada.
Pantuck, E. J., Hsio, K. C., Loub, W. D., Wattenberg, L. W., Kuntzman, R., & Conney, A. H. (1976). Stimulatory effect of vegetables on intestinal drug metabolism in the rat. Journal of Pharmacology and Experimental Therapeutics, 198, 278–283.
Ritschel, W. A. (1992). Handbook of basic pharmacokinetics (4th ed.). Hamilton: Drug Intelligence Publications.
Rowland, M., & Tozer, T. N. (1995). Clinical pharmacokinetics: Concepts and applications (3rd ed.). Philadelphia: Lippincott Williams & Wilkins.
Sari, I. P. (1999). Antaraksi farmakokinetika brokoli (Brassica oleraceae L. vabrotrytis L.)–kinidin: Kajian terhadap akibat dan perantara antaraksi. Yogyakarta: Fakultas Farmasi, Universitas Gadjah Mada.
Tjay, H. T., & Rahardja, K. (2002). Obat-obat penting (Edisi ke-5). Jakarta: Direktorat Jenderal Pengawasan Obat dan Makanan, Departemen Kesehatan Republik Indonesia.
Vogel, H. G. (2002). Drug discovery and evaluation: Pharmacological assays. Springer.
Zimmerman, H. J., & Maddrey, W. C. (1995). Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of instances of therapeutic misadventure. Hepatology, 22(3), 767–773
